Achieving a "grand convergence" in global health: Modeling the technical inputs, costs, and impacts from 2016 to 2030

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Boyle, Colin F ^a   Levin, Carol ^b   Hatefi, Arian ^a   Madriz, Solange ^a   Santos, Nicole ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD HEALTH; CONTROLLED STUDY; COST; ECONOMIC ASPECT; HEALTH; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVESTMENT; MALARIA; MATERNAL WELFARE; REPRODUCTION; SCALE UP; SUSTAINABLE DEVELOPMENT; TUBERCULOSIS; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE COST; HIV INFECTIONS; MORTALITY; SOCIOECONOMICS; TRENDS;

CHILD HEALTH; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALARIA; MORTALITY; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 84948663298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140092     Document Type: Article

References (34)

1. Preston SH. Human mortality throughout history and prehistory. The State of Humanity. First. Malden, Massachusetts: Blackwell publisher Inc; 1995.
2. Galor O, Moav O. The Neolithic Origins of Contemporary Variations in Life Expectancy [Internet]. Rochester, NY: Social Science Research Network; 2007 Oct. Report No.: ID 1012650. Available: http://papers.ssrn.com/abstract=1012650
3. World Bank. Country and Lending Groups | Data [Internet]. 22 Oct 2013 [cited 28 Jun 2014]. Available: http://data.worldbank.org/about/country-and-lending-groups#Low-income
4. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, et al. Global health 2035: a world converging within a generation. Lancet 2013; 382:1898-955. doi: 10.1016/S0140-6736(13)62105-4 PMID: 24309475
5. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011; 377: 2031-2041. doi: 10.1016/S0140- 6736(11)60702-2 PMID: 21641026
6. Roll Back Malaria Partnership. Refined/updated GMAP objectives, targets, milestones and priorities beyond 2011 [Internet]. Roll Back Malaria Partnership; 2011. Available: http://www.rollbackmalaria.org/ gmap/gmap2011update-fr.pdf
7. World Health Organization. Global tuberculosis report 2013 [Internet]. Geneva; 2012. Available: http:// www.who.int/tb/publications/global-report/en/
8. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013; 382: 452-477. doi: 10.1016/S0140-6736(13)60996-4 PMID: 23746776
9. GAVI Alliance. Vaccine investment strategy [Internet]. 2008 [cited 28 Jun 2014]. Available: http://www. gavialliance.org/about/strategy/vaccine-investment-strategy/
10. Horton S, Shekar M, McDonald C, Mahal A, Krystene Brooks J. Scaling up nutrition:What will it cost? [Internet]. World Bank; 2010. Available: http://siteresources.worldbank.org/HEALTHNUTRITIONAND POPULATION/Resources/Peer-Reviewed-Publications/ScalingUpNutrition.pdf
11. Røttingen J-A, Chamas C. A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG). PLoS Med. 2012; 9: e1001219. doi: 10.1371/journal.pmed.1001219 PMID: 22615545
12. Stenberg K, Axelson H, Sheehan P, Anderson I, Gülmezoglu AM, Temmerman M, et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet. 2014; 383: 1333-1354. doi: 10.1016/S0140-6736(13)62231-X PMID: 24263249
13. Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, Weissman E, et al. Stillbirths: what difference can we make and at what cost? Lancet. 2011; 377: 1523-1538. doi: 10.1016/S0140-6736(10)62269-6 PMID: 21496906
14. World Health Organization. Investing in maternal, newborn and child health: the case for Asia and the Pacific [Internet]. World Health Organization; 2009. Available: http://www.who.int/pmnch/topics/ investinginhealth.pdf
15. Harmonization for Health in Africa. Investing in Health for Africa. The case for strengthenin systems for better health outcomes [Internet]. Available: http://www.afro.who.int/en/clusters-a-programmes/hss/ cluster/hha.html
16. Taskforce on Innovative International Financing for Health Systems. More morney for health, and more health for the money [Internet]. 2009. Available: http://www.hanshep.org/resources/further-reading/ taskforce-for-innovative-international-financing-for-health-systems-2009-report
17. Open Working Group on Sustainable, Development Goals. Proposal for Sustainable Development Goals; Outcome of United Nations General Assembly [Internet]. Available: http:// sustainabledevelopment.un.org/focussdgs.html
18. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S. Supplementary Web Appendices. Global Health 2035. Supplementary Web Appendices. http://globalhealth2035.org/supplementary-webappendices (accessed 30 Jun2014).
19. Futures Institute. One Health Tool [Internet]. 2011 [cited 2014 Jun 28]. Available from: http://www. futuresinstitute.org/onehealth.aspx.
20. Walker N, Tam Y, Friberg IK. Overview of the Lives Saved Tool (LiST). BMC Public Health 2013; 13: S1. doi: 10.1186/1471-2458-13-S3-S1 PMID: 24564438
21. The Partnership for Maternal, Newborn and Child Health. Country stillbirth rates per 1000 total births for 2009 [Internet]. Available: http://www.who.int/pmnch/media/news/2011/stillbirths-countryrates.pdf
22. Dasgupta S, Blankespoor A, Lagnaoui A. Heath costs and benefits of DDT use in malaria control and prevention [Internet]. World Bank Policy Research Working Paper 6203; 2012. Available: http://econ. worldbank.org/WBSITE/EXTERNAL/EXTDEC/EXTRESEARCH/0, , contentMDK:23305014~ pagePK:64214825~piPK:64214943~theSitePK:469382, 00.html
23. White MT, Conteh L, Cibulskis R, Ghani AC. Costs and cost-effectiveness of malaria control interventions- a systematic review. Malar J 2011; 10: 337. doi: 10.1186/1475-2875-10-337 PMID: 22050911
24. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach June 2013. [Internet]. Available: http://apps.who. int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf
25. Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global Epidemiology of Tuberculosis. Cold Spring Harb Perspect Med. 2015; 5: a017798. doi: 10.1101/cshperspect.a017798
26. Jamison DT, Sandbu M, Wang J. Why has infant mortality decreased at such different rates in different countries? Disease Control Priorities Project. 2004.
27. Organization WH, others. The work of WHO in the African region [Internet]. Brazzaville; 2013. Available: http://apps.who.int/iris/handle/10665/42510
28. Seddoh A, Onyeze A, Gyapong JO, Holt J, Bundy D. Towards an Investment Case for Neglected Tropical Diseases. 2013; Available: http://www.schoolsandhealth.org/Shared%20Documents/Downloads/ Towards%20an%20Investment%20Cases%20for%20NTDS-%20Lancet%20July%202013.pdf
29. Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, et al. Budget impact analysis- principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014; 17: 5-14. doi: 10.1016/j.jval.2013.08.2291 PMID: 24438712
30. Financing Global Health 2011: Continued Growth as MDG Deadline Approaches [Internet]. [cited 28 Jun 2014]. Available: http://www.healthdata.org/policy-report/financing-global-health-2011-continuedgrowth- mdg-deadline-approaches
31. Sepúlveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Oláiz G, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet. 2006; 368: 2017-2027. doi: 10.1016/S0140-6736(06)69569-X PMID: 17141709
32. Progress towards Millennium Development Goals 4 and 5; Building a Future for Women and Children. The 2012 Report [Internet]. Available: http://www.countdown2015mnch.org/documents/2012Report/ 2012-part-2.pdf
33. Clark H. Towards a more robust investment framework for health. Lancet 2013; 7:e36-7.
34. Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012; 11: 191-200. doi: 10.1038/nrd3681 PMID: 22378269